effect of betahistine and dimenhydrinate in benign paroxysmal positional vertigo

Phase 2

• Conditions: Benign paroxysmal vertigo.; benign paroxysmal positional vertigo

• Registration Number: IRCT201506231138N20
• Lead Sponsor: Guilan University of Medical Science, Vice Chancellor for Resarch

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Unknown BPPV; Successful epley maneuver; Patients who don't receive any medication.

Exclusion criteria:
The inner ear disease; The inner or middle ear surgery; Migraine and headache during the study period; Using Psycho-neurological drugs during the study; The involvement more than one of a semi-circular canal; Re-Appearance of nystagmus after epley maneuver.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ightheadedness. Timepoint: Before starting the medication, and 1 week after starting drug. Method of measurement: Physical examination.;Diagnosis of BPPV. Timepoint: at the first study, One week after epley maneuver. Method of measurement: hallpike dix test.;Feeling of floating. Timepoint: Before starting the medication, and 1 week after starting drug. Method of measurement: Physical examination.;Dizziness. Timepoint: Before starting the medication, and 1 week after starting drug. Method of measurement: Physical examination.;Ear fullness. Timepoint: Before starting the medication, and 1 week after starting drug. Method of measurement: Physical examination.;Weakness. Timepoint: Before starting the medication, and 1 week after starting drug. Method of measurement: Physical examination.

Secondary Outcome Measures

Name	Time	Method
Quality of life. Timepoint: Before and after intervention. Method of measurement: The questionnaire Dizziness Handicap Inventory (DHI) and Berg balance scale (modified).;Daily activities. Timepoint: Before and after intervention. Method of measurement: The questionnaire Dizziness Handicap Inventory (DHI) and Berg balance scale (modified).;Disease severity. Timepoint: Before and after intervention. Method of measurement: The questionnaire Dizziness Handicap Inventory (DHI) and Berg balance scale (modified).;Emotional state. Timepoint: Before and after intervention. Method of measurement: The questionnaire Dizziness Handicap Inventory (DHI) and Berg balance scale (modified).